Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 324 | 6,071 | 7,002 | 7,077 |
| Receivables | N/A | N/A | 205 | 277 | 115 |
| Other current assets | 0 | 141 | 0 | 0 | 0 |
| TOTAL | $N/A | $465 | $6,276 | $7,279 | $7,192 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 379 | 314 | 328 |
| Intangibles | 0 | 913 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 353 | 379 | 397 |
| TOTAL | $N/A | $913 | $732 | $693 | $725 |
| Total Assets | $N/A | $1,378 | $7,008 | $7,972 | $7,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,213 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 4,889 | 650 | 743 | 1,132 |
| Accrued Expenses | N/A | 1,008 | N/A | N/A | N/A |
| Other current liabilities | N/A | 875 | N/A | N/A | N/A |
| TOTAL | $N/A | $7,985 | $786 | $863 | $1,250 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 466 | 821 | 535 |
| TOTAL | $N/A | $N/A | $466 | $821 | $535 |
| Total Liabilities | $N/A | $7,985 | $1,252 | $1,684 | $1,785 |
| Shareholders' Equity | |||||
| Retained earnings | N/A | -6,607 | -33,087 | -32,377 | -29,009 |
| Other shareholders' equity | 0 | 0 | 4,982 | 5,070 | 4,778 |
| TOTAL | $N/A | $-6,607 | $5,756 | $6,288 | $6,132 |
| Total Liabilities And Equity | $0 | $1,378 | $7,008 | $7,972 | $7,917 |